Ofer Gonen

Biography

Mr. Gonen has been with CBI since 2003. He manages the company’s life sciences investments, business development, US-based operations, and investment support for CBI’s portfolio companies. Mr. Gonen serves as an executive chairman and board member of several companies (Gamida Cell, MediWound (NASDAQ: MDWD), CureTech, D-Pharm (TASE: DPRM), Biocancell (TASE: BICL), Avraham, Campus Bio, Polyheal, CLS). Prior to joining CBI, Mr. Gonen was the general manager of Biomedical Investments as well as a technology consultant to various Israeli venture capital funds and an Academic Aide to the Governor of the Bank of Israel. Mr. Gonen gained extensive experience in R&D and management in defense-oriented projects within the prestigious “TALPIOT” program of the Israeli Defence Forces, for which he was awarded the Israeli National Security Medal. Mr. Gonen holds an M.A. in Economics and Finance from the Tel Aviv University, and a B.Sc. in Physics, Mathematics and Chemistry from the Hebrew University in Jerusalem.

Research Interest

Pharmaceutical Sciences